{"id":"559090-2788","orgnr":"559090-2788","name":"2A Pharma AB","name_registered_on":"2016-12-12","legal_form":{"code":"AB","name":"Aktiebolag"},"status":"registered","registered_on":"2016-12-12","business_description":"Bolaget ska bedriva forskning, utveckling och kommersialisering av läkemedel samt därmed förenlig verksamhet.","industries":[{"code":"72109","name":"Annan naturvetenskaplig och teknisk forskning och utveckling"}],"postal_address":{"street":"Båtbyggaregatan 44","postal_code":"21642","city":"LIMHAMN","country":"SE","municipality":{"code":"1280","name":"Malmö"},"county":{"code":"12","name":"Skåne län"}},"registered_office":{"municipality":{"code":"1280","name":"Malmö"},"county":{"code":"12","name":"Skåne län"}},"activity_status":"active","employee_class":{"code":"1","name":"0 anställda"},"turnover_class":{"code":"0","name":"< 1 tkr","year":2025},"f_tax":"registered","vat":"registered","employer":"registered","registry_source":{"dataset":"bolagsverket_bulkfil","published_on":"2026-11-16"},"annual_reports":[{"from":"2025-01-01","to":"2025-12-31","framework":"K2","signed_on":"2026-06-30","documents":{"annual_report":"/v1/documents/3c6e967a-39e5-4147-8efe-c099c23a59c7.xhtml","audit_report":"/v1/documents/6999e821-5b4e-4717-aa1c-4455f58fa0f2.xhtml"},"source":{"dataset":"arsredovisningar","file":"2026/31_8.zip"}}],"latest_financials":{"from":"2025-01-01","to":"2025-12-31","scope":"company","currency":"SEK","net_sales":-1,"other_operating_income":725,"operating_profit":-414889,"profit_after_financial_items":-3042607,"net_profit":-3042607,"total_assets":401081,"current_assets":19439,"equity":117306,"share_capital":143303,"unrestricted_equity":-25997,"current_liabilities":283775,"cash":11293,"staff_costs":0,"equity_ratio":0.292,"source":{"annual_report":"2025-12-31","document":"/v1/documents/3c6e967a-39e5-4147-8efe-c099c23a59c7.xhtml"},"anchors":{"cash":{"text":"11 293","prefix":"Summa kassa och bank","suffix":"114 000"},"current_assets":{"text":"19 439"},"current_liabilities":{"text":"283 775"},"equity":{"text":"117 306"},"equity_ratio":{"text":"29,2"},"net_sales":{"text":"1","suffix":"1"},"operating_profit":{"text":"414 889"},"other_operating_income":{"text":"725"},"profit_after_financial_items":{"text":"3 042 607"},"share_capital":{"text":"143 303","prefix":"utgång"},"staff_costs":{"text":"0","prefix":"2"},"total_assets":{"text":"401 081","prefix":"TILLGÅNGAR"},"unrestricted_equity":{"text":"25 997","suffix":"Styrelsen"}}},"officers":{"annual_report":"2025-12-31","signed_on":"2026-06-30","signatories":[{"name":"P*****","role":"Verkställande direktör"},{"name":"P*****","role":"Styrelseordförande"},{"name":"J*****","role":"Styrelseledamot"}],"auditors":[{"name":"M*****","title":"Auktoriserad revisor","firm":"Deloitte AB"},{"name":"M*****","title":"Auktoriserad revisor","firm":"Deloitte AB"}]},"group":{"subsidiaries":[{"name":"2A Pharma ApS","depth":1,"seat":"Aalborg Øst","capital_share":1,"source":{"by":"parent","annual_report":"2025-12-31"}}],"list":{"annual_report":"2025-12-31","signed_on":"2026-06-30","completeness":"unknown","shares_in_group_companies":381642,"currency":"SEK","listed":1}}}